Quantum Corp /De/
$1.10B- Market cap
- $974.61M
- Debt
- +$144.85M
- Cash
- −$15.57M
Capital structure 87% equity / 13% debt · EV / Revenue 3.95x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: QMCO stock price at discount vs IONS $24.73 current versus $72.57 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IONS's multiple
Implied fair value · at QMCO's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: QMCO FY 2026 (ended Mar 31, 2026) · IONS FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 87% equity / 13% debt · EV / Revenue 3.95x
Capital structure 81% equity / 19% debt · EV / Revenue 9.77x
IONS carries the larger enterprise value at $9.22B against $1.10B; QMCO trades on the lower EV / Revenue multiple (3.95x vs 9.77x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
QUANTUM CORP /DE/ · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Ionis Pharmaceuticals, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-0.73x
4.59x
Net debt / EBITDA
Leverage against operating earnings
-1.55x
1.34x
Cash and equivalents
Liquid reserves on the balance sheet
$15.57M
$2.68B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Pure Storage, Inc.
QMCO vs PSTG
NetApp, Inc.
QMCO vs NTAP
Dell Technologies Inc.
QMCO vs DELL
Super Micro Computer, Inc.
QMCO vs SMCI
Sarepta Therapeutics, Inc.
QMCO vs SRPT
Moderna, Inc.
QMCO vs MRNA
Natera, Inc.
QMCO vs NTRA
ILLUMINA, INC.
QMCO vs ILMN
AMGEN INC
QMCO vs AMGN
VERTEX PHARMACEUTICALS INC / MA
QMCO vs VRTX
$144.85M
$2.24B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.